Chefaa, Egypt’s patient-centred pharmacy benefits platform, has announced raising a venture round from Newtown Partners and Global Brain as well as GMS Capital Partners.

The undisclosed round is part of Chefaa’s journey to further expand its network, support the release of its Chefaa Prime product, a complete medical insurance alternative designed for emerging markets and launch officially in new markets.

Moreover, this venture round will fund Chefaa efforts to digitise chronic illness management through a comprehensive approach to achieve measurable improvement in chronic patients’ quality of life.

This is also the three VCs’ first venture into the Egyptian market.